Home > Boards > Free Zone > Big Board Trading - Technical >

Biotech Ideas

RSS Feed
      Hide Sticky   Hide Intro
Moderator: gfp927z Assistants:
Search This Board: 
Last Post: 5/8/2021 11:36:02 PM - Followers: 5 - Board type: Free - Posts Today: 0

A board to discuss biotech ideas -


Bio-Path Holdings (BPTH) - Oncology, RNAi nano particle drugs, delivery platform - (B) -- (34 mil)
Cardiff Oncology (CRDF) - Cancer (36) ---------------------------------------------------------- (B) -- (462 mil)
Corvus Therapeutics (CRVS) - Immuno-oncology therapies  (51) ------------------------ (B) -- (101 mil)
Curis (CRIS) - Cancer (23) ---------------------------------------------------------------------------- (B) -- (932 mil)
F-star Therapeutics, Inc. (FSTX) - Tetravalent bispecific antibodies for cancer (UK)  (B) -- (94 mil) 
Kazia Therapeutics (KZIA) - Cancer (Australia) ------------------------------------------------ (B) -- (92 mil)
Magenta Therapeutics (MGTA) - Autoimmune, MAB conjugates (145) ------------------ (B) -- (482 mil)
Myovant (MYOV) - Prostate cancer, women's health, endocrine diseases (745) (UK) (B) -- (1.9 Bil)
Oncternal Therapeutics (ONCT) - Cancer (21) ------------------------------------------------ (B) -- (402 mil)
Provention Bio (PRVB) - Immune-mediated diseases (76) ---------------------------------- (B) -- (944 mil)
Trillium Therapeutics (TRIL) - Immuno-oncology (Canada) -------------------------------- (B) -- (1.3 Bil) 


ChemoCentryx (CCXI) - Inflammatory, autoimmune, cancer (72) -------------------------- (B) -- (4.2 Bil)
Enanta Pharma (ENTA) - Viral infections, liver diseases -------------------------------------- (D) -- (1.0 Bil)
Kura Oncology (KURA) - Cancer (236) ----------------------------------------------------------- (B-- (2.2 Bil)
Macrogenics (MGNX) - Cancer, MABs, conjugates (170------------------------------------ (B) -- (1.1 Bil)
MEI Pharma (MEIP) - Cancer (200) ----------------------------------------------------------------- (B) -- (452 mil)
Revance Therapeutics (RVNC) - Neuromodulators for aesthetics, therapeutics ------- (D) -- (1.9 Bil)
Xenon Pharmaceuticals (XENE) - Neurological (141) (Canada) --------------------------- (B) -- (514 mil)


OTHER - 
************


Gamida Cell (GMDA) - Cell therapies for cancer, blood diseases (Israel) --------------- (M) -- (529 mil) 
Oramed (ORMP) - Diabetes, oral delivery system for polypeptides ----------------------- (M) -- (264 mil)

Protalix (PLX) - Plant cell-based expression system for recombinant proteins (Israel) (M) -- (217 mil) 

Axsome Therapeutics (AXSM) - CNS disorders ------------------------------------------------------ (2.8 Bil)
Humanigen (HGEN) - MABs for immunotherapy and cancer, Covid ----------------------------- (1.1 Bil)
Innovation Pharma (IPIX) - Brilacidin (Polymedix) (formerly Cellceutix), Covid -------------- (120 mil)
VistaGen (VTGN) - Neurological --------------------------------------------------------------------------- (340 mil)

Otonomy (OTIC) - Neurotology (ears) ------------------------------------------------------------ (B) -- (245 mil)
Pieris Pharma (PIRS) - Asthma, respiratory, inflam, cancer, kidney ---------------------- (B) -- (174 mil)
Synlogic (SYBX) - Metabolic, inflam, cancer ----------------------------------------------------------- (171 mil)



___________________________________________________________________
 

SPDR S&P Biotech ETF (XBI) (Exp - 0.35%, Assets - 3.5 Bil, Yld - 0.01%)

Name Symbol % Assets
Regeneron Pharmaceuticals Inc REGN 2.77%
Moderna Inc MRNA 2.65%
Gilead Sciences Inc GILD 2.43%
Vertex Pharmaceuticals Inc VRTX 2.32%
Biogen Inc BIIB 2.28%
United Therapeutics Corp UTHR 2.26%
Biomarin Pharmaceutical Inc BMRN 2.25%
Seattle Genetics Inc SGEN 2.16%
Exelixis Inc EXEL 2.06%
ACADIA Pharmaceuticals Inc ACAD 2.04%

__________________________________________________________________________

First Trust NYSE Arca Biotech Index (FBT) (Exp - 0.57%, Assets - 1.5 Bil, Yld - 0)

 

Name Symbol % Assets
Regeneron Pharmaceuticals Inc REGN 4.88%
Gilead Sciences Inc GILD 4.58%
Qiagen NV QGEN 4.48%
Biogen Inc BIIB 4.28%
Seattle Genetics Inc SGEN 4.08%
United Therapeutics Corp UTHR 3.93%
Vertex Pharmaceuticals Inc VRTX 3.89%
ACADIA Pharmaceuticals Inc ACAD 3.75%
Biomarin Pharmaceutical Inc BMRN 3.69%
Alnylam Pharmaceuticals Inc ALNY 3.53%

________________________________________________________________________
 

ARK Genomic Revolution ETF (ARKG) (Exp - 0.75%, Assets - 7.7 Bil, Yld - 0.85%)

 

Name Symbol % Assets
Pacific Biosciences of California Inc PACB 6.85%
Teladoc Health Inc TDOC 5.94%
CRISPR Therapeutics AG CRSP 5.77%
Twist Bioscience Corp TWST 5.72%
CareDx Inc CDNA 3.87%
Iovance Biotherapeutics Inc IOVA 3.59%
Exact Sciences Corp EXAS 3.58%
Fate Therapeutics Inc FATE 3.47%
Invitae Corp NVTA 3.42%
Personalis Inc PSNL 3.26%


_____________________________________________________________________________
 
PostSubject
#263   >>> Humanigen Announces Publication of Results From Phase gfp927z 05/08/21 11:36:02 PM
#262   >>> Why Humanigen Stock Vaulted Higher Today gfp927z 05/08/21 11:53:33 AM
#261   >>> Dynavax Announces First Quarter 2021 Financial Results gfp927z 05/08/21 11:27:39 AM
#260   >>> F-star Therapeutics Reports Full-Year 2020 Financial Results gfp927z 05/07/21 04:41:32 PM
#259   >>> F-star Therapeutics, Inc. Announces Pricing of $65 gfp927z 05/07/21 04:20:59 PM
#258   >>> The origin of COVID: Did people or gfp927z 05/06/21 11:19:34 PM
#257   >>> Innovation Pharma Surpasses 50 Percent Enrollment in gfp927z 04/28/21 09:13:37 PM
#256   >>> Synthetic Biologics, Inc. (SYN), a clinical-stage company, gfp927z 04/28/21 11:19:13 AM
#255   >>> Axsome Therapeutics Announces FDA Acceptance and Priority gfp927z 04/27/21 11:55:53 AM
#254   MindMed To Commence Trading on Nasdaq - Uplisting PyroStocks 04/25/21 07:52:28 PM
#253   Interesting comment on Seeking Alpha with Biotech Ideas conix 04/23/21 09:14:54 AM
#252   >>> Humanigen Reports Positive Data With Lenzilumab in gfp927z 04/19/21 12:27:20 PM
#251   >>> Scientist behind Pfizer vaccine: mRNA shots for gfp927z 04/18/21 12:38:48 AM
#250   >>> Humanigen Announces Positive Results From Phase 1 gfp927z 04/18/21 12:25:00 AM
#249   >>> Innovation Pharma’s Broad Spectrum Antiviral Drug Candidate gfp927z 04/18/21 12:21:01 AM
#248   >>> Dynavax (DVAX) Up on Positive COVID-19 Vaccine gfp927z 04/16/21 12:36:57 PM
#247   >>> Why Dynavax Stock Jumped Today gfp927z 04/16/21 12:29:24 PM
#246   >>> A key component of J&J vaccine could gfp927z 04/14/21 04:58:49 PM
#245   >>> Dynavax’s CpG 1018 Used In Valneva’s COVID-19 gfp927z 04/14/21 02:33:28 PM
#244   >>> Innovation Pharma Announces Brilacidin Abstract Accepted for gfp927z 04/11/21 04:14:09 PM
#243   A good overview of the various types of gfp927z 04/11/21 03:35:45 PM
#242   >>> Blood Clots Linked to AZ Vaccine Stem gfp927z 04/11/21 12:46:15 PM
#241   >>> Provention Bio Provides Regulatory Update on Biologics gfp927z 04/08/21 07:32:15 PM
#240   >>> Could Humanigen Stock Soar Even Higher After gfp927z 04/08/21 02:24:25 PM
#239   >>> PDS Biotechnology Corporation (PDSB), a clinical-stage biopharmaceuti gfp927z 04/08/21 10:46:32 AM
#238   >>> Innovation Pharma Completes Interim Safety Data Review—DMC gfp927z 04/05/21 01:23:12 PM
#237   >>> Immunocontraception gfp927z 04/02/21 04:57:47 PM
#236   >>> Facebook Built the Perfect Platform for gfp927z 04/02/21 12:30:58 PM
#235   >>> The Placental Protein Syncytin-1 Impairs Antiviral Responses gfp927z 04/02/21 12:26:58 PM
#234   >>> Virus Variant in Brazil Infected Many Who gfp927z 04/01/21 02:20:48 PM
#233   >>> Clover Biopharmaceuticals and Dynavax Announce First Participants gfp927z 03/31/21 03:25:56 PM
#232   >>> Kite and Humanigen Announce Clinical Collaboration to gfp927z 03/29/21 06:12:44 PM
#231   >>> Humanigen Reports Positive Phase 3 Topline Results gfp927z 03/29/21 11:59:30 AM
#230   >>> Humanigen Announces Positive Interim Phase 3 Data gfp927z 03/28/21 11:03:28 PM
#229   >>> Humanigen Reports Fourth Quarter and Year-End 2020 gfp927z 03/19/21 12:14:58 AM
#228   >>> Existing COVID vaccines may protect against Brazilian gfp927z 03/18/21 07:02:34 PM
#227   >>> RespireRx Pharmaceuticals Inc. Announces Appointment of Dr. gfp927z 03/17/21 01:20:32 PM
#226   >>> Surface Oncology Reports Financial Results and Corporate gfp927z 03/17/21 03:18:13 AM
#225   >>> Surface Oncology, Inc. (SURF), a clinical-stage immuno-oncology gfp927z 03/17/21 03:07:44 AM
#224   >>> The Vaccines Aren’t Actually Vaccines gfp927z 03/13/21 10:30:02 PM
#223   >>> Axsome Therapeutics Reports Fourth Quarter and Full gfp927z 03/13/21 09:20:20 PM
#222   >>> VistaGen Therapeutics, Inc. (VTGN), a clinical-stage biopharmaceutica gfp927z 03/13/21 08:08:01 PM
#221   >>> VistaGen’s PH10 Nasal Spray Demonstrates Different Mechanism gfp927z 03/13/21 08:06:24 PM
#220   >>> Magenta Is Ready to Paint Your Portfolio Green gfp927z 03/12/21 10:01:10 PM
#219   >>> Innovation Pharmaceuticals Announces Publication of Peer-Reviewed Sci gfp927z 03/12/21 09:24:08 PM
#218   >>> Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian gfp927z 03/12/21 09:14:30 PM
#217   Innovation Pharma - >>> Recruitment and Enrollment Underway gfp927z 03/12/21 09:09:14 PM
#216   >>> Oncternal Therapeutics Provides Business Update and Announces gfp927z 03/12/21 12:38:44 PM
#215   Enlivex - video of mechanism - gfp927z 03/11/21 08:04:19 PM
#214   >>> Has Israel just found the cure for Covid? gfp927z 03/11/21 07:41:57 PM
PostSubject
Consent Preferences